Venous Thromboembolism
Showing 1 - 25 of 431
Glioblastoma, Venous Thromboembolism, Seizures Trial in Cleveland (Apple Watch)
Not yet recruiting
- Glioblastoma
- +2 more
- Apple Watch
-
Cleveland, OhioCleveland Clinic Taussig Cancer institute, Case Comprehensive Ca
Nov 13, 2023
Venous Thromboembolism, Venous Thromboses, Pulmonary Embolism Trial in Netherlands (Randomised treatment advice (discontinue vs
Recruiting
- Venous Thromboembolism
- +3 more
- Randomised treatment advice (discontinue vs continue after 3 months)
- +4 more
-
Leiden, South-Holland, Netherlands
- +16 more
Oct 17, 2023
Venous Thromboembolism Trial in Beijing
Recruiting
- Venous Thromboembolism
-
Beijing, Beijing, ChinaChinese Academy of Medical Sciences Fuwai Hospital
Oct 5, 2023
Anticoagulant, Venous Thromboembolism, Prophylaxis Trial in Denmark (Dalteparin Prefilled Syringe, Tinzaparin profiled syringe)
Recruiting
- Anticoagulant
- +3 more
- Dalteparin Prefilled Syringe
- Tinzaparin profiled syringe
-
Copenhagen, Denmark
- +8 more
Aug 29, 2023
United Sates That Looks at Safety and Effectiveness of Pradaxa
Not yet recruiting
- Venous Thromboembolism
- (no location specified)
Aug 1, 2023
Venous Thromboembolism in Primary Pancreatic Tumour Resection
Not yet recruiting
- Venous Thromboembolism
- +2 more
-
Larissa, Thessaly, GreeceUniversity Hospital of Larissa
Jul 27, 2023
Tumor Metastasis, Blood Coagulation Disorder With Shortened Coagulation Time (Disorder), Venous Thromboembolism Trial in Tianjin
Recruiting
- Neoplasm Metastasis
- +2 more
- CGT test
-
Tianjin, Tianjin, ChinaTianjin Medical University General Hospital
Jul 1, 2023
Thromboprophylactic Dosage Nadroparin in Critically Ill COVID-19
Completed
- Critical Illness
- +2 more
- blood sampling
-
Arnhem, NetherlandsMonique de Maat
Jun 28, 2023
Venous Thromboembolism, Urologic Cancer Trial (Rivaroxaban 10 MG, Placebo control)
Not yet recruiting
- Venous Thromboembolism
- Urologic Cancer
- Rivaroxaban 10 MG
- Placebo control
- (no location specified)
Jun 16, 2023
Women's Preferences for Postpartum Thromboprophylaxis:
Completed
- Venous Thromboembolism
- Pregnancy Related
- Interview
-
Paris, France
- +1 more
Jun 9, 2023
Safety of Rivaroxaban in Children Under 2 Years Old With Venous
Not yet recruiting
- Venous Thromboembolism
- Children Under 2 Years
- Rivaroxaban (Xarelto, BAY59-7939)
- Standard of care (SOC)
-
Multiple Locations, Denmark
- +3 more
Jun 9, 2023
Pulmonary Embolism, Venous Thromboembolism, Metabolomics Trial in Boston (Oxygen Therapy, Non-rebreather mask)
Not yet recruiting
- Pulmonary Embolism
- +3 more
- Oxygen Therapy
- Non-rebreather mask
-
Boston, MassachusettsMassachusetts General Hospital
May 26, 2023
Transurethral Resection, Wearable Devices, Venous Thromboembolism Trial (Socks Developed with Wearable Technology)
Not yet recruiting
- Transurethral Resection
- +4 more
- Socks Developed with Wearable Technology
- (no location specified)
Jun 2, 2023
Deep Vein Thrombosis, Venous Thromboembolism, Pulmonary Embolism Trial (Celect Platinum Vena Cava Filter)
Not yet recruiting
- Deep Vein Thrombosis
- +2 more
- Celect Platinum Vena Cava Filter
- (no location specified)
May 30, 2023
Venous Thromboembolism Trial in Geneve (Enoxaparin)
Completed
- Venous Thromboembolism
-
Geneve, SwitzerlandGeneva University Hospitals
May 24, 2023
Model for Venous Thromboembolism Following Neurosurgery
Recruiting
- Venous Thromboembolism
- +2 more
- Clinical Prediction Model for Venous Thromboembolism Following Neurosurgery
-
Beijing, ChinaSanbo Brain Hospital, Capital Medical University
May 6, 2023
Extended Versus Conventional Duration of Enoxaparin Prophylaxis
Not yet recruiting
- Venous Thromboembolism
- (no location specified)
Apr 6, 2023
Venous Thromboembolism and Bleeding Events inPopulation of Obese
Not yet recruiting
- Venous Thromboembolism
- (no location specified)
Apr 6, 2023
Trauma Injury, Thromboembolism, Venous Thromboembolism Trial in Houston (Thrombate infusion, Placebo)
Not yet recruiting
- Trauma Injury
- +2 more
- Thrombate infusion
- Placebo
-
Houston, TexasThe University of Texas Health Science Center at Houston
Mar 28, 2023
Peripartum Anticoagulation manaGement for thrOmboembolism
Not yet recruiting
- Pregnancy Related
- Venous Thromboembolism
-
Calgary, Alberta, CanadaFoothills Medical Centre
Feb 21, 2023
Venous Thromboembolism, Varicose Veins Trial in London (Dalteparin Sodium, Tinzaparin Sodium, Enoxaparin Sodium)
Not yet recruiting
- Venous Thromboembolism
- Varicose Veins
- Dalteparin Sodium
- +5 more
-
London, United KingdomImperial College Hospital NHS Foundation Trust
Feb 20, 2023
Venous Thromboembolism, Deep Venous Thrombosis, Post-Thrombotic Syndrome Trial in Denver, Pittsburgh (ClotTriever System,
Recruiting
- Venous Thromboembolism
- +2 more
- ClotTriever System
- Commercially available/market approved anticoagulation medication including but not limited to: Heparin Sodium, Coumadin, Rivaroxaban, Apixaban, etc.
-
Denver, Colorado
- +1 more
Jan 18, 2023
Sarcoma, Soft Tissue Sarcoma, Bone Sarcoma Trial in Boston (Aspirin 325mg, Enoxaparin 40Mg/0.4mL Prefilled Syringe)
Enrolling by invitation
- Sarcoma
- +6 more
- Aspirin 325mg
- Enoxaparin 40Mg/0.4mL Prefilled Syringe
-
Boston, MassachusettsSantiago Lozano-Calderon
Jan 20, 2023
Post Thrombotic Syndrome : OPTIMEV Study ( SPOT )
Completed
- Post Thrombotic Syndrome
- +2 more
- Villalta phone score > or = to 5
- Villalta phone score < 5
-
Grenoble, FranceCHU Grenoble Alpes
Jan 20, 2023